Vidwan-ID : 169391

Edit Profile

    Score criteria

Criteria Point
Personal Details 1
Expertise Details 1
Experience Details 1
Qualification Details 1
Employee ID 0.2
Orcid ID 0.2
Researcher ID 0.2
Scopus ID 0.2
Google Scholar ID 0.2
Honours <=3< /td> 0.3
Honours >3 0.5
Project worth less than Rs.5,00,000/- 0.2
Project worth more than Rs.5,00,000/- 0.5
Membership in professional Bodies < 5 0.5
Membership in professional bodies >=5 1
No of publications <=15 1
No of publications between 15-45 2
No of publications >45 3

Vidwan Score 7.8

78% Complete
18 Articles
4 Books
1 Projects

Dr Jahnavi Bandla

Assistant Professor
Vishnu Institute of Pharmaceutical Education and Research

Publications

  • 18
    Journal Articles
  • 4
    Book
  • 3
    Conference
    Proceedings
  • 1
    Projects

Citations / H-Index

9 Citations
2 h-index
2 Citations



Co-author Network


Expertise

Department of Pharmaceutical Analysis & QA

Personal Information

Dr Jahnavi Bandla

1988 Female
Kukatpally Vishnu Institute Of Pharmaceutical Education And Research, Narsapur
Medak, Telangana, India - 502314


Experience in Months

Academic: 10 Administrative: 0 Industry: 0

Experience

  • Assistant Professor

    Department of Pharmaceutics

    Vishnu Institute of Pharmaceutical Education and Research, Medak


Qualification

  • Ph.D

    GITAM Institute of Pharmacy


Doctoral Theses Guided

2020

Validation, quantification and stress degradation studies on antiviral and anticancer drugs in formulations using chromatographic tools

GITAM University,Jahnavi Bandla

2020

Validation, quantification and stress degradation studies on antiviral and anticancer drugs in formulations using chromatographic tools

GITAM University,Jahnavi Bandla

Read Less

Membership In Professional Bodies

2021

IPA

Life member

2013

APTI

Life member

2021

IPA

Life member

2013

APTI

Life member

Read Less

Research Projects

Nitric oxide releasing quinolones derivatives as inhibitors of doxorubicin resistance in cancer

Funding Agency : AICTE

Nitric oxide releasing quinolones derivatives as inhibitors of doxorubicin resistance in cancer

Funding Agency : AICTE

Read Less

Patents





Read Less

Publications (25)